wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45879084-44FD5841-3737-436F-ACFD-341BDF9F5102
Q45879084-44FD5841-3737-436F-ACFD-341BDF9F5102
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45879084-44FD5841-3737-436F-ACFD-341BDF9F5102
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders.
P2860
Q45879084-44FD5841-3737-436F-ACFD-341BDF9F5102
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45879084-44FD5841-3737-436F-ACFD-341BDF9F5102
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
54f2e9280096c7f4b7223dd9cae65666b80c7cd9
P2860
Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.